Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot
Abstract Background Hepatitis C virus (HCV) infections are a public health burden worldwide and often go undetected until sequelae develop. Offering HCV screening for the different vulnerable populations in community pharmacies could help prevent further undetected HCV infections. This pilot aimed t...
Main Authors: | Dominik Stämpfli, Tamara Leila Imfeld-Isenegger, Kurt E. Hersberger, Markus Messerli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-023-08362-1 |
Similar Items
-
Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?
by: Helene Studer, et al.
Published: (2020-02-01) -
Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact
by: Tamara L Imfeld-Isenegger, et al.
Published: (2020-03-01) -
A Telementoring Program and Hepatitis C Virus Care in Rural Patients
by: Ping Du, et al.
Published: (2021-05-01) -
The role of community pharmacies in the HIV and HCV care continuum
by: Sorosh Kherghehpoush, et al.
Published: (2023-03-01) -
Occult hepatitis C virus infection in Iranian hemodialysis patients
by: Ali Eslamifar, et al.
Published: (2015-10-01)